While these results are needed to be confirmed with further studies, to our knowledge, this is the first study that identified a potential prognostic significance of the MTHFR Glu429Ala polymorphism in colorectal cancer patients not treated with 5-FU. Here, MTHFR is linked to colorectal cancer.